(Q33370619)
Statements
Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients (English)
Francisco Javier Peñalver
Manuel Almagro
Alberto Alvarez-Larrán
Lluis Rodríguez
Marisol Casado
Laura Gallur
Pilar Giraldo
Roberto Hernández
Dolores Menor
Maria José Rodríguez
Dolores Caballero
Raúl González
José Mayans
Isabel Millán
José Rafael Cabrera
Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP